期刊文献+

纤维支气管镜介导治疗耐多药肺结核的临床分析 被引量:22

Clinical efficiency of intervention with bronchofiberosopy on multi-drug resistant pulmonary tuberculosis
下载PDF
导出
摘要 目的探讨纤维支气管镜(简称纤支镜)导管介导结核空洞内注药对耐多药肺结核的治疗效果。方法将63例耐多药肺结核病患者分为治疗组和对照组,治疗组采用纤支镜灌注治疗加全身化疗,对照组只进行全身化疗。进行痰涂片检查、胸部X线或者CT检查、肝肾功能检查。结果疗程结束时,治疗组咯血症状明显改善,其痰菌转阴率87.0%、病灶吸收率83.8%、空洞闭合缩小率74.1%,明显高于单纯化疗组的59.3%、56.2%、40.6%,差异具有统计学意义(P<0.05)。治疗组和对照组分别有3例和7例出现一过性肝功能异常,应用保肝降酶药后恢复正常。结论经纤支镜给药配合全身化疗耐多药肺结核疗效显著,优于单纯全身化疗。 Objective To evaluate the clinical efficiency of intervention with bronchofiberoscopy in treatment of mud-drug resistant pulmonary tuberculosis. Methods Sixty-three patients with identified multi- drug resistant pulmonary tuberculosis in our department from 2007 to 2009 were randomly divided into experi- ment group ( n = 31 ) and control group ( n = 32 ). The experiment group was treated by bronchial lavage with bronchofiberoscopy once per 2 weeks for 9 to 15 times and general anti-tuberculotic treatment, and the control group only received the later treatment. Sputum smear examination, chest X-ray filming/CT scanning, and liver and renal function were carried out. Results At the end of treatment, the symptoms ( such as cough and hae- moptysis) were greatly improved, the sputum negative conversion was 87.0%, the foei absorption was 83.8%, and cavity close was 74.1% in the experiment group, with the later 3 parameters significantly higher than those of control group (59.3% , 56.2% and 40.6% , P 〈0. 05). There were liver dysfunction in 3 cases of experi- ment group and 7 cases of control group. They all recovered after routine treatment with hepato-protective and transaminase-descending drugs. Conclusion Bronchial lavage with bronchofiberoscopy combined with chemo- therapy exerts significant effect in the treatment of multi-drug resistant pulmonary tuberculosis, superior to chemotherapy alone.
作者 雷霆 缪李丽
出处 《第三军医大学学报》 CAS CSCD 北大核心 2013年第6期573-575,共3页 Journal of Third Military Medical University
关键词 耐多药肺结核 纤维支气管镜 治疗 multidrug-resistant pulmonary tuberculosis bronchofiberoscopy treatment
  • 相关文献

参考文献11

二级参考文献35

共引文献72

同被引文献227

  • 1罗敬福.复方甘草酸苷联合双环醇治疗抗结核药所致药物性肝炎36例[J].中国医学前沿杂志(电子版),2013,5(11):35-37. 被引量:3
  • 2曾熙玲,初乃惠,刘志敏.耐药结核病辅助治疗的进展[J].结核病与肺部健康杂志,2013,2(4). 被引量:7
  • 3程书权.抗结核药物性肝损害172例临床分析[J].药物流行病学杂志,2004,13(4):195-198. 被引量:23
  • 4中华医学会结核病学会.肺结核诊断和治疗指南[J]中华结核和呼吸杂志,2001(02).
  • 5Kashyap S, Mohapatra PR, Saini V.Endobronchial tubercu- losis[J].Idian J Chest Dis Allied Sci, 2003,45 (4) : 247-256.
  • 6Lee TH,Sin Fai Lam KN.Endobronchial tuberculosis simu- lating bronchial asthma[J].Singapore Med J,2004,45 (8): 390-392.
  • 7LEIBERT E, DANCKERS M, ROM WN. New drugs to treat? multidrug-resistant tuberculosis: the case for bedaquiline [J]. Ther Clin Risk Manag, 2014, 29(10): 597-602.
  • 8HO J, JELFS P, SINTCHENKO V. Fluoroquinolone resistance in non-muhidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates[J]. Int J Infect Dis, 2014, 26(10): 149-153.
  • 9GOMEZ M, CHURCH LW, JUDSON MA. Tuberculous mediasti- nal lymphadenitis that evolved into pulmonary?tuberculosis?follow- ing transbronchial needle aspiration [J]. Respirology, 2010, 15(7): 1140-1141.
  • 10KO Y, LEE HY, LEE YS, et al. Esophagomediastinal fistula secondary to multidrug-resistant tuberculous mediastinal lym- phadenitis[J]. Intern Med, 2014, 53(16): 1819-1824.

引证文献22

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部